Published on May 25, 2007
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the
Board of Directors
Novelos
Therapeutics, Inc.
We
consent to the use of our report dated March 19, 2007 in the Registration
Statement of Novelos Therapeutics, Inc. on Form SB-2, relating to the
registration of 23,400,000 shares of common stock. We also consent to the use
of
our name and the reference to us in the ‘‘Experts’’ section of this registration
statement.
/s/
Stowe & Degon
Worcester,
MA
May
25,
2007